Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Conditions: Diabetic Kidney Disease; Type 1 Diabetes
Interventions: Drug: Semaglutide; Other: Placebo
Sponsors: University of Washington; Juvenile Diabetes Research Foundation; University of Colorado, Denver; Providence Healthcare; University of Toronto
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 7, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments